Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion type Assertion NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_head.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion description "[Gene expression profile of KMS11 cells showed 22 upregulated and 52 downregulated genes upon RPI-1 treatment, with an early modulation of genes implicated in MM pathobiology such as SAT-1, MYC, MIP-1alpha/beta, FGF-R3, and the growth factor receptor B-cell maturation antigen (BCMA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_provenance.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion evidence source_evidence_literature NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_provenance.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion SIO_000772 19555670 NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_provenance.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion wasDerivedFrom befree-20140225 NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_provenance.
- NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_assertion wasGeneratedBy ECO_0000203 NP256209.RA6sPwfpbHQaBe2Ztj0KeRa9bdX-6peHyHL1fPsftR2G8130_provenance.